TRAW - Traws Pharma, Inc.
1.6
-0.080 -5.000%
Share volume: 33,124
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$1.68
-0.08
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 18.172 M | 18.686 M | 8.936 M | 19.063 M | 15.622 M | 12.443 M | |
| Current Assets | 18.153 M | 18.671 M | 8.923 M | 18.856 M | 15.370 M | 9.625 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 16.390 M | 16.886 M | 5.410 M | 15.937 M | 13.081 M | 6.420 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 18.000 K | 14.000 K | 12.000 K | 9.000 K | 8.000 K | 7.000 K | |
| Other Assets | 1.000 K | 1.000 K | 1.000 K | 198.000 K | 244.000 K | 2.811 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 18.172 M | 18.686 M | 8.936 M | 19.063 M | 15.622 M | 12.443 M | |
| Total liabilities | 12.157 M | 12.587 M | 10.969 M | 13.063 M | 7.360 M | 7.898 M | |
| Total current liabilities | 9.422 M | 9.910 M | 8.348 M | 10.401 M | 7.352 M | 7.887 M | |
| Accounts Payable | 6.568 M | 6.174 M | 5.472 M | 7.656 M | 4.759 M | 5.105 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 154.000 K | 8.000 K | 11.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 154.000 K | 8.000 K | 11.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.015 M | -105.520 M | -2.033 M | 6.000 M | 8.262 M | 4.545 M | |
| Common stock | 493.659 M | 505.270 M | 617.232 M | 633.683 M | 636.832 M | 637.080 M | |
| Retained earnings | -487.614 M | -610.757 M | -619.232 M | -627.664 M | -628.579 M | -632.541 M |